Does ENZALUTAMIDE Cause Musculoskeletal stiffness? 244 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 244 reports of Musculoskeletal stiffness have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.5% of all adverse event reports for ENZALUTAMIDE.
244
Reports of Musculoskeletal stiffness with ENZALUTAMIDE
0.5%
of all ENZALUTAMIDE reports
11
Deaths
31
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From ENZALUTAMIDE?
Of the 244 reports, 11 (4.5%) resulted in death, 31 (12.7%) required hospitalization.
Is Musculoskeletal stiffness Listed in the Official Label?
Yes, Musculoskeletal stiffness is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOFACITINIB (7,354)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
Which ENZALUTAMIDE Alternatives Have Lower Musculoskeletal stiffness Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE